JP2022523123A5 - - Google Patents
Info
- Publication number
- JP2022523123A5 JP2022523123A5 JP2021544728A JP2021544728A JP2022523123A5 JP 2022523123 A5 JP2022523123 A5 JP 2022523123A5 JP 2021544728 A JP2021544728 A JP 2021544728A JP 2021544728 A JP2021544728 A JP 2021544728A JP 2022523123 A5 JP2022523123 A5 JP 2022523123A5
- Authority
- JP
- Japan
- Prior art keywords
- trem2
- optionally
- cell
- acid sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024210953A JP2025032191A (ja) | 2019-02-01 | 2024-12-04 | 神経認知障害を処置するための組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962800056P | 2019-02-01 | 2019-02-01 | |
| US62/800,056 | 2019-02-01 | ||
| PCT/US2020/016163 WO2020160441A1 (en) | 2019-02-01 | 2020-01-31 | Compositions and methods for treating neurocognitive disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024210953A Division JP2025032191A (ja) | 2019-02-01 | 2024-12-04 | 神経認知障害を処置するための組成物及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022523123A JP2022523123A (ja) | 2022-04-21 |
| JP2022523123A5 true JP2022523123A5 (https=) | 2023-04-25 |
Family
ID=71841290
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544728A Pending JP2022523123A (ja) | 2019-02-01 | 2020-01-31 | 神経認知障害を処置するための組成物及び方法 |
| JP2024210953A Pending JP2025032191A (ja) | 2019-02-01 | 2024-12-04 | 神経認知障害を処置するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024210953A Pending JP2025032191A (ja) | 2019-02-01 | 2024-12-04 | 神経認知障害を処置するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220133850A1 (https=) |
| EP (1) | EP3917623A4 (https=) |
| JP (2) | JP2022523123A (https=) |
| CA (1) | CA3127804A1 (https=) |
| IL (1) | IL285268A (https=) |
| MA (1) | MA54873A (https=) |
| WO (1) | WO2020160441A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190248A1 (ar) | 2017-04-21 | 2019-10-20 | Amgen Inc | بروتينات ربط مولد ضد trem2 واستخداماته |
| WO2022006105A2 (en) * | 2020-07-02 | 2022-01-06 | Avrobio, Inc. | Compositions and methods for treating neurocognitive disorders |
| WO2023196470A1 (en) * | 2022-04-07 | 2023-10-12 | The Regents Of The University Of California | Methods for treating alzheimer's disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1461087A1 (en) * | 2001-12-06 | 2004-09-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders |
| WO2014074942A1 (en) * | 2012-11-08 | 2014-05-15 | Illumina, Inc. | Risk variants of alzheimer's disease |
| WO2017147509A1 (en) * | 2016-02-25 | 2017-08-31 | Marco Colonna | Compositions comprising trem2 and methods of use thereof |
| CN109641961A (zh) * | 2016-07-22 | 2019-04-16 | 德国神经退行性疾病研究中心 | Trem2切割调节剂及其用途 |
| BR112020001060A2 (pt) * | 2017-07-27 | 2020-07-14 | Novartis Ag | variantes de trem2 resistentes a shedase |
-
2020
- 2020-01-31 CA CA3127804A patent/CA3127804A1/en active Pending
- 2020-01-31 US US17/427,429 patent/US20220133850A1/en active Pending
- 2020-01-31 JP JP2021544728A patent/JP2022523123A/ja active Pending
- 2020-01-31 MA MA054873A patent/MA54873A/fr unknown
- 2020-01-31 WO PCT/US2020/016163 patent/WO2020160441A1/en not_active Ceased
- 2020-01-31 EP EP20748276.1A patent/EP3917623A4/en active Pending
-
2021
- 2021-08-01 IL IL285268A patent/IL285268A/en unknown
-
2024
- 2024-12-04 JP JP2024210953A patent/JP2025032191A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022523913A5 (https=) | ||
| JP2022523514A5 (https=) | ||
| US11434504B2 (en) | Adeno-associated virus vector variants for high efficiency genome editing and methods thereof | |
| Rittiner et al. | Gene-editing technologies paired with viral vectors for translational research into neurodegenerative diseases | |
| US20140341852A1 (en) | Capsid-modified raav vector compositions and methods therefor | |
| JP2021517168A5 (https=) | ||
| Muraine et al. | Transduction efficiency of adeno-associated virus serotypes after local injection in mouse and human skeletal muscle | |
| US8278428B2 (en) | Mitochondrial nucleic acid delivery systems | |
| US20110207226A1 (en) | Non-integrating lenti/adeno-associated virus hybrid vector system | |
| US12031148B2 (en) | RNA adeno-associated virus (RAAV) vector and uses thereof | |
| US20220307053A1 (en) | Regulatable expression systems | |
| JP2022523123A5 (https=) | ||
| CA3076191A1 (en) | Variant rnai | |
| JP7616668B2 (ja) | Ｕｂｅ３ａ遺伝子および発現カセットならびにそれらの使用 | |
| Minskaia et al. | Viral vectors in gene replacement therapy | |
| US20210332368A1 (en) | Compositions and methods to restore paternal ube3a gene expression in human angelman syndrome | |
| WO2024120528A1 (en) | Improved system for producing rna-packaged aav particles | |
| US20250171778A1 (en) | Treatments of Disorders of Myelin | |
| JP2023529371A5 (https=) | ||
| US12358954B2 (en) | Capsid-modified rAAV vector compositions and methods therefor | |
| CA3217699A1 (en) | Novel aav serotypes derived from a library screen | |
| US20070280906A1 (en) | Method to generate mirrored adenoassociated viral vectors | |
| Silver et al. | Towards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies | |
| JP2023507885A5 (https=) | ||
| US20240366680A1 (en) | Treatment of pain |